![Pavel Raifeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pavel Raifeld
Vorstandsvorsitzender bei
INNOVIVA, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Pavel Raifeld is currently Chief Executive Officer & Director at La Jolla Pharmaceutical Co. since 2023, Chief Executive Officer & Director at Innoviva, Inc. since 2025, Chief Executive Officer at Theravance Respiratory Co. LLC, President & Director at Tetraphase Pharmaceuticals, Inc., President & Director at Entasis Therapeutics Holdings, Inc. since 2022, and President & Director at Entasis Therapeutics, Inc. Formerly, Mr. Raifeld was Senior Member-Healthcare Investment Banking at Credit Suisse Securities (USA) LLC.
Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at Harvard University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INNOVIVA, INC. 0,39 % | 20.05.2026 | 285 929 ( 0,39 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Pavel Raifeld
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOVIVA, INC. | Vorstandsvorsitzender | 20.05.2020 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Präsident | 11.07.2022 |
| LA JOLLA PHARMACEUTICAL COMPANY | Vorstandsvorsitzender | 01.04.2023 |
| TETRAPHASE PHARMACEUTICALS, INC. | Präsident | - |
Theravance Respiratory Co. LLC
 Theravance Respiratory Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures inhaled corticosteroid products | Vorstandsvorsitzender | - |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Präsident | - |
Ehemalige bekannte Positionen von Pavel Raifeld
| Unternehmen | Position | Ende |
|---|---|---|
Credit Suisse Securities (USA) LLC
 Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Corporate Officer/Principal | - |
Ausbildung von Pavel Raifeld
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Credit Suisse Securities (USA) LLC
Credit Suisse Securities (USA) LLC Regional BanksFinance Provides investment banking, asset management and securities brokerage services | Finance |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Theravance Respiratory Co. LLC
Theravance Respiratory Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures inhaled corticosteroid products | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
